Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate Cancer

Abstract

Background: The clinical outcome for the individual prostate cancer patient is often difficult to predict, due to lack of reliable independent prognostic biomarkers. We tested DNA ploidy as a prognostic factor for clinical outcome in 186 patients treated with radical prostatectomy.